Cancer
UNMC technologies in the oncology field available for licensing
Showing all 11 results
-
Claudin-1 Inhibitors
Read more -
GGDPS Inhibitors
Read more -
NF-κB Pathway Inhibitor
Read more -
CCL21-based immunotherapy for cancer
Read more -
Target for cancer stem cells
Read more -
Breast cancer biomarker
Read more -
Prostate cancer cells
Read more -
NF-kB inhibitors
Read more -
Nanogel cancer treatment
Read more